Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Predictors of Glucocorticoid Responsiveness in Multicentric Castleman's Disease

Kazutoshi Ebisawa, MD, Arika Nukina Shimura, MD, Akira Honda, MD PhD, Yosuke Masamoto, MD PhD, Fumio Nakahara, MD PhD, Mineo Kurokawa, MD PhD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-136469

Published: 2020

Journal Articles

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Toshiaki Takezaki, MD, Akira Honda, MD PhD, Yasunori Kogure, MD PhD, Akira Chiba, MD, Fumihiko Nakamura, MD PhD, Kumi Nakazaki, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5242.

https://doi.org/10.1182/blood-2019-124597

Published: 2019

Journal Articles

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

Akira Honda, MD PhD, Yu Oyama, MD, Kazuhiro Toyama, MD PhD, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5492.

https://doi.org/10.1182/blood-2019-129324

Published: 2019

Journal Articles

The Nationwide Study of Erdheim-Chester Disease in Japan

Mizuki Ogura, MD, PhD, Takashi Toya, MD, PhD, Akihide Yoshimi, MD, PhD, Aya Shinozaki Ushiku, MD, PhD, Akira Honda, MD, PhD, Toyama Kazuhiro, MD, PhD, Kenjiro Honda, MD, PhD, Yasuhito Nannya, MD, PhD, Yusuke Shinoda, MD, PhD, Akiko M. Saito, MD PhD, Takashi Ogura, MD, Ichiro Katayama, MD, PhD, Kiyoshi Miyagawa, MD, PhD, Masaomi Nangaku, MD, PhD, Masashi Fukayama, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 4879.

https://doi.org/10.1182/blood.V128.22.4879.4879

Published: 2016

Journal Articles

Identification of Somatic Mutation Contributing to Chemotherapy Resistance in Acute Myeloid Leukemia

Akira Honda, MD, PhD, Junji Koya, MD, PhD, Akihide Yoshimi, MD PhD, Keisuke Kataoka, MD PhD, Shunya Arai, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 600.

https://doi.org/10.1182/blood.V128.22.600.600

Published: 2016

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Masashi Miyauchi, MD, PhD, Shunya Arai, MD, PhD, Akira Honda, MD PhD, Sho Yamazaki, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Kazuki Taoka, MD, PhD, Keiki Kumano, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 1878.

https://doi.org/10.1182/blood.V128.22.1878.1878

Published: 2016

NARROW

Predictors of Glucocorticoid Responsiveness in Multicentric Castleman's Disease

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

The Nationwide Study of Erdheim-Chester Disease in Japan

Identification of Somatic Mutation Contributing to Chemotherapy Resistance in Acute Myeloid Leukemia

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

Predictors of Glucocorticoid Responsiveness in Multicentric Castleman's Disease

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Bortezomib Overcomes Poor Prognosis Conferred By High Sictp in Untreated Plasma Cell Disorders

The Nationwide Study of Erdheim-Chester Disease in Japan

Identification of Somatic Mutation Contributing to Chemotherapy Resistance in Acute Myeloid Leukemia

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only